A RETROSPECTIVE ANALYSIS OF THE EFFICACY AND SAFETY OF REGORAFENIB IN PATIENTS WITH CHEMO-REFRACTORY COLORECTAL CANCER

被引:0
|
作者
Oishi, Takayuki [1 ]
Takahashi, Masanobu [2 ]
Shiono, Masatoshi [2 ]
Takahashi, Shin [1 ]
Akiyama, Shoko [2 ]
Shirota, Hidekazu [2 ]
Shimodaira, Hideki [2 ]
Kato, Shunsuke [1 ]
Ishioka, Chikashi [1 ]
机构
[1] Tohoku Univ, IDAC, Dept Clin Oncol, Sendai, Miyagi 980, Japan
[2] Tohoku Univ Hosp, Dept Clin Oncol, Sendai, Miyagi, Japan
关键词
D O I
10.1093/annonc/mdu436.27
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P1-12-2
引用
收藏
页数:1
相关论文
共 50 条
  • [21] A retrospective cohort study evaluating the safety and efficacy of regorafenib in patients with metastatic colorectal cancer [HGCSG1401]: Analysis of tumor location
    Satoshi, Yuki
    Yoshito, Komatsu
    Tetsuhito, Muranaka
    Yasushi, Tsuji
    Kazuaki, Harada
    Yumiko, Ota
    Kazuteru, Hatanaka
    Hiroyuki, Okuda
    Takahide, Sasaki
    Masayoshi, Dazai
    Jun, Konno
    Michio, Nakamura
    Tomoyuki, Ohta
    Takuya, Honda
    Atsushi, Ishiguro
    Osamu, Muto
    Sosuke, Kato
    Atsushi, Sato
    Masakazu, Abe
    Kazunori, Eto
    Naoya, Sakamoto
    Yuh, Sakata
    ANNALS OF ONCOLOGY, 2017, 28
  • [22] Modulation of autophagy: A phase II study of vorinostat (VOR) plus hydroxychloroquine (HCQ) vs regorafenib (RGF) in chemo-refractory metastatic colorectal cancer (mCRC).
    Arora, Sukeshi Patel
    Tenner, Laura LaNiel
    Sarantopoulos, John
    Morris, Jay Larry
    Longoria, Lisa
    Liu, Qianqian
    Michalek, Joel
    Mahalingam, Devalingam
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [23] FOLFOX rechallenge versus regorafenib in patients with metastatic colorectal cancer refractory to standard chemotherapy: A retrospective analysis.
    Calegari, Maria Alessandra
    Zurlo, Ina Valeria
    Di Stefano, Brunella
    Camarda, Floriana
    Di Dio, Carmela
    Garufi, Giovanna
    Cassano, Alessandra
    Barone, Carlo Antonio
    Bria, Emilio
    Basso, Michele
    Orlandi, Armando
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [24] Updated survival analysis of the Danish randomized study comparing trifluridine/tipiracil with or without bevacizumab in patients with chemo-refractory metastatic colorectal cancer
    Pfeiffer, P.
    Winther, S.
    Yilmaz, M.
    Moller, S.
    Zitnjak, D.
    Poulsen, L.
    Thomsen, K.
    Qvortrup, C.
    ANNALS OF ONCOLOGY, 2020, 31 : S214 - S214
  • [25] The Efficacy and Safety of Regorafenib in Combination With Anti-PD-1 Antibody in Refractory Microsatellite Stable Metastatic Colorectal Cancer: A Retrospective Study
    Li, Jisheng
    Cong, Lei
    Liu, Jintao
    Peng, Ling
    Wang, Jun
    Feng, Alei
    Yue, Jinbo
    Li, Li
    Wang, Xiuwen
    Wang, Xiangling
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [26] An International Consortium in Chemo-refractory Metastatic Colorectal Cancer Patients Shows Cetuximab Efficacy in Patients Harboring HER2 Gene Copy Number Gain
    Martin, V.
    Sacconi, A.
    Landi, L.
    Riva, A.
    Saletti, P.
    Geva, R.
    Tejpar, S.
    Kalogeras, K.
    Frattini, M.
    Cappuzzo, F.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S396 - S396
  • [27] Preliminary Efficacy and Safety of Camrelizumab in Combination With XELOX Plus Bevacizumab or Regorafenib in Patients With Metastatic Colorectal Cancer: A Retrospective Study
    Zhou, Hong
    Wang, Yuehui
    Lin, Yanfang
    Cai, Wenjie
    Li, Xiaofeng
    He, Xiaomeng
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [28] Regorafenib and trifluridine/tipiracil efficacy and safety in chemorefractory metastatic colorectal cancer patients: A single Bulgarian centre retrospective study
    Penkova, M.
    Stoyanov, D.
    Panayotova, T.
    Donev, I.
    Petrova, M.
    Conev, N.
    ANNALS OF ONCOLOGY, 2020, 31 : S100 - S100
  • [29] The efficacy of abiraterone acetate in treating Taiwanese chemo-refractory metastatic castration-resistant prostate cancer patients
    Wu, Tony
    Wu, Hsi Chin
    Ou, Yen Chuan
    Pang, See-Tong
    Pu, Yeong-Shiau
    Chang, Yen-Hwa
    UROLOGICAL SCIENCE, 2016, 27 (04) : 218 - 222
  • [30] Efficacy and Safety of the Oral Multikinase Regorafenib in Metastatic Colorectal Cancer
    Cicero, Giuseppe
    De Luca, Rossella
    Dieli, Francesco
    ONCOLOGY, 2017, 93 (06) : 354 - 358